Publication by Boontanrart et al.: Engineering of the endogenous HBD promoter increases HbA2.

Recently published eLife paper by the Corn group (IMHS) demonstrates that using CRISPR-​Cas9 gene-​editing to insert transcription factor binding sites can increase transcriptional activity and expression of Hemoglobin A2.